Safety Assessment of SAR341402 and NovoLog® Used in Continuous Subcutaneous Insulin Infusion for Type 1 Diabetes Mellitus Patients
Clinical trial NCT03436498 · COMPLETED
Trial details
- NCT number
- NCT03436498
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-10
- Primary completion
- 2018-10-06
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.